APA (7th ed.) Citation

D, A., R, R., G, M., A, B., T, S., P, T., & MR, R. (2021). Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab. Dove Medical Press.

Chicago Style (17th ed.) Citation

D, Allegrini, Raimondi R, Montesano G, Borgia A, Sorrentino T, Tsoutsanis P, and Romano MR. Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab. Dove Medical Press, 2021.

MLA (8th ed.) Citation

D, Allegrini, et al. Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab. Dove Medical Press, 2021.